CN102485912A - Research on GeXP multi-PCR technology for detecting and parting human papilloma virus (HPV) - Google Patents
Research on GeXP multi-PCR technology for detecting and parting human papilloma virus (HPV) Download PDFInfo
- Publication number
- CN102485912A CN102485912A CN2010105679519A CN201010567951A CN102485912A CN 102485912 A CN102485912 A CN 102485912A CN 2010105679519 A CN2010105679519 A CN 2010105679519A CN 201010567951 A CN201010567951 A CN 201010567951A CN 102485912 A CN102485912 A CN 102485912A
- Authority
- CN
- China
- Prior art keywords
- hpv
- research
- pcr
- hpv6
- parting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention which belongs to the biotechnological application field relates to a research on GeXP multi-PCR technology for detecting and parting HPV, and concretely relates to the detection and the typing of markers of cervical secretions and the like infected with various HPV subtypes (comprising HPV6, HPV11, HPV31, HPV33 and HPV52) in disease prevention control mechanisms at all levels, hospitals and the like. The research is concretely carried out by analyzing conserved sequences of HPV subtype genes with computer software, respectively designing specific primers aiming at the subtypes, and carrying out single-tube multi-PCR (six-PCR) (comprising Rnasep-DNA), wherein the whole reaction lasts for less than 2h. The research which overcomes a disadvantage of no parting of routine single-tube multiple fluorescent qualitative PCR detections and also overcomes disadvantages of complex operation, long time, high cost and the like of routine chip detection methods provides a new idea for HPV parting technologies, and characteristics of high specificity, high sensitivity and rapidness of the research provide strong technological supports for the realization of the rapid and accurate screening and discrimination of HPV subtype infection, so the research has important meanings to research the HPV infection type distribution characteristic of a patient and improve the control level of cancer pathologies caused by the HPV subtypes.
Description
Invention field
The invention belongs to biological technology application; Relate to Disease Prevention and Control Institutions at different levels, the various human papilloma virus HPV hypotype that Sentinel point hospital etc. is used for samples such as cervical secretionses (comprises HPV6, HPV11; HPV31, HPV33 and HPV52) detect and somatotype when infecting.Concrete conserved sequence through each subtype gene of computer software analysis human papillomavirus HPV is designed the type specificity primer to each hypotype respectively, carries out single tube multiple (6 weight) PCR (comprising internal control gene Rnasep-DNA), and entire reaction was less than 2 hours.This patent both overcome conventional single tube multi-fluorescence qualitative PCR detect can not somatotype shortcoming; Also overcome the complex operation of conventional chip detecting method; Time is longer; The more high shortcoming of cost; For the typing method of HPV provides new thinking, its height is special, highly sensitive, characteristics are differentiated for the examination quick and precisely that realizes the HPV hypotype and infect fast provides strong technical support, and it is significant with the level of preventing and treating that improves the cancerous lesion that is caused by each hypotype of HPV that research patient HPV is infected the type characteristic distributions.
Background of invention
Cervical cancer is a kind of malignant tumour of serious harm WomanHealth, and sickness rate occupies second in women's malignant tumour, still occupies first in some developing countries and regions.According to the global range statistics, cervical cancer accounts for 10% in all gynecologic malignant tumors, and 471,000 routine new cases and 215,000 routine deaths are arranged every year.Human papillomavirus (HPV) is closely related with cervical cancer; It is a kind of double-stranded cyclic DNA virus; Form by early gene, late gene (late gene L1 and L2 encode respectively main capsid protein and less important capsid protein) and upstream regulation district three parts of not translating; Discover that the cervical cancer more than 99% has HPV to infect, HPV is the main virulence factor of cervical cancer.The relation of foundation and cervical cancer is divided into high-risk-type and low risk with HPV, and high-risk-type comprises: HPV16,18,31,33,35,39,45,51,52,56,58,66, types such as 69; Low risk comprises: 6, types such as 11,43,44.In the high-risk hypotype of HPV, the infection rate of southern area of China 52, the 58 hypotypes north is high, in Taiwan except that HPV16,18; 31,33,35 infection rate is higher; Explanation 16,18,31,33,52,58 is the most common hypotype in Chinese, but because Chinese region is broad, populous; So the data of this respect comparatively lacks, remain further to be studied.In the low danger hypotype, HPV6,11 is common infection hypotype, can cause diseases such as huge condyloma, pointed condyloma, respiratory tract papilloma, papilloma of conjunctiva.To further study pathogenic, treatment and the prognosis situation of different subtype HPV in different ethnic populations; Understand the variation tendency of HPV clinical infection type and generation and the death that reduces cervical cancer, just need set up a kind of novel method clinical application, that can carry out the detection of examination and somatotype simultaneously to all known high-risk types and common low danger type HPV that is suitable for.So the common HPV31 of Chinese is tentatively chosen in this research, 33,52 three kinds of high-risk-types and HPV6,11 two kinds of low risks are as research object.
At present, the HPV classifying method has a lot, and common have cytology detection method and a Protocols in Molecular Biology method, tests (HC), hybridization in situ technique (ISH) and PCR method etc. like liquid-basedcytology technology and smear Automatic Measurement Technique, hybrid capture.Wherein, round pcr is comparatively ripe, has characteristics such as quick, easy, sensitivity.Since substance PCR flux not high limitation; A kind of novel multiple PCR technique based on GeXP is adopted in this research; It adopts universal primer to cause the target gene amplification, can effectively solve the amplification preferences in the multiplex PCR process, the detection sensitivity and the resolving power that adopt capillary electrophoresis and fluorescent mark amplified production to improve; According to amplified production fragment length judged result, help to improve detection specificity.In our previous work, utilization has successfully detected new influenza A virus and seasonal influenza virus based on the multiple PCR technique of GeXP.This research at first detects HPV6,11,31 with the substance round pcr; The HPV clinical sample that 33 and 52 substances infect with the specificity of checking GeXP primer, has been set up a kind of novel multiple GeXP-PCR technology for detection on this basis; To detect and to identify the common HPV6 of Chinese in the RTI simultaneously; Hypotypes such as 11,31,33 and 52.
Summary of the invention
1. the primer sequence of announcing with GenBank is reference; Downloading known array from NCBI uses CLUSTAL X software to carry out sequence alignment; Choose for being directed against each target gene high conservative for the constant gene segment C of other type high special; By eXpress Profiler Software design sixfold primer, like table 1:
Table 1 GeXP detects the nucleotide primer sequence table of human papillomavirus (HPV)
Annotate: what underscore was represented is upstream and downstream universal primer sequences
2. set up following testing process, seen for details as follows:
(1) synthetic primer: synthetic and purifying by Shanghai Ying Jun company.
(2) sample to be measured is pressed the DNA Mini Kit test kit step process of Qiagen company, obtained the DNA of sample.
(3) 6 heavy PCR reactions.
Embodiment
The reaction system of embodiment 1:Gexp multiplex PCR and condition
Adopt 25 μ l PCR reaction systems, wherein contain: Ex Taq12.5 μ l, upstream and downstream chimeric primers mixture (1 μ mol/L) 1.25 μ l, upstream and downstream universal sequence primer (10 μ mol/L) 1.25 μ l, dna profiling 1 μ l, the sterilization distilled water complements to 25 μ l.The pcr amplification condition is: 94 ℃, and 10min; (95 ℃, 30s; 56 ℃, 30s; 72 ℃, 30s) * 5 circulation; (95 ℃, 30s; 68 ℃, 30s; 72 ℃, 30s) * 15 circulation; (95 ℃, 30s; 48 ℃, 30s; 72 ℃, 30s) * 20 circulation; 72 ℃, 5min.
The specificity of embodiment 2:Gexp multiplex PCR
As template, do the multiplex PCR amplification with the hybrid dna of known five hypotypes with six pairs of primers (containing internal control gene RNasep-DNA) mixed solution.The result shows that the gene of 5 kinds of HPV subtype virus can be detected simultaneously, has verified the specificity of the medium-sized special primer of multiple detection architecture.
The sensitivity of embodiment 3:Gexp multiplex PCR
HPV6,11,31,33,52 five cloned plasmids carry out 10 times of serial dilutions after quantitatively, artificially mix five hypotype DNAs, concentration be respectively 10
6Copies/ μ l, 10
5Copies/ μ l, 10
4Copies/ μ l, 10
3Copies/ μ l, 10
2Copies/ μ l, 10
1The mixed solution of copies/ μ l is made sample to be checked, carries out the sensitivity analysis of GeXP multiple PCR method, and the system that the Gexp multiplex PCR detects is with embodiment 1.The result shows, 10
3Copy/μ L level can the simultaneously special simulation mixing sample that detects 5 kinds of HPV subtype virus.Each concentration is all at non-triplicate on the same day, the coming to the same thing of acquisition.
Embodiment 4: clinical sample analysis and checking
The result that the GeXP multiplex PCR detects 30 parts of clinical samples shows: the HPV6 substance infects 5 parts, and the HPV11 substance infects 4 parts, and the HPV31 substance infects 2 parts; The HPV33 substance infects 5 parts; The HPV52 substance infects 6 parts, 2 parts of HPV6/52 double infections, 1 part of HPV6/11/33 multiple infection.The result is by human papillomavirus nucleic acid amplification parting detecting reagent (Guangdong Chaozhou Kaipu Biochemistry Co., Ltd.) checking, and is in full accord.GeXP multiplex PCR detection architecture is with embodiment 1.
Claims (5)
1. one kind is used for detecting simultaneously human papillomavirus HPV6, HPV11, and HPV31, the multiple PCR technique of HPV33 and HPV52, comprising: be used for human papillomavirus HPV6, HPV11, HPV31, type specificity primer and universal primer that HPV33 and HPV52 detect.
2. the primer of claim 1 described multiple PCR technique and universal primer comprise the gene order that table 1 is listed and the complementary sequence or the variant of every kind of sequence thereof.
3. claim 1 described multiplex PCR detection technique comprises human papillomavirus HPV6, HPV11, HPV31, HPV33 and HPV52 and variant thereof.
4. claim 3 described ranges of application of the present invention comprise Disease Prevention and Control Institutions at different levels, and hospital is used for human papillomavirus HPV6, HPV11, and HPV31, HPV33 and HPV52 detect and somatotype simultaneously.
5. the claim 1 described human papillomavirus HPV6 that detects simultaneously, HPV11, HPV31, the response procedures of the multiple PCR technique of HPV33 and HPV52 and trace routine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105679519A CN102485912A (en) | 2010-12-01 | 2010-12-01 | Research on GeXP multi-PCR technology for detecting and parting human papilloma virus (HPV) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105679519A CN102485912A (en) | 2010-12-01 | 2010-12-01 | Research on GeXP multi-PCR technology for detecting and parting human papilloma virus (HPV) |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102485912A true CN102485912A (en) | 2012-06-06 |
Family
ID=46151486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010105679519A Pending CN102485912A (en) | 2010-12-01 | 2010-12-01 | Research on GeXP multi-PCR technology for detecting and parting human papilloma virus (HPV) |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102485912A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102994647A (en) * | 2012-06-21 | 2013-03-27 | 宁波海尔施基因科技有限公司 | Typing and quantitative detection method and kit for human papilloma virus (HPV) |
CN113755641A (en) * | 2021-08-10 | 2021-12-07 | 中国疾病预防控制中心病毒病预防控制所 | Primer probe set and kit for isothermal nucleic acid amplification for detecting human papilloma virus types 16 and 18 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1496413A (en) * | 2003-05-09 | 2004-05-12 | 清华大学 | Method for multiple PCR condition optimization and its component |
CN1536088A (en) * | 2003-04-11 | 2004-10-13 | 徐定邦 | PCR method of multiple primer, its reaction liquor and application for preparing detection reagent |
CN101851630A (en) * | 2009-03-30 | 2010-10-06 | 白向阳 | Human papillomavirus HPV DNA fragment, specific primer and application thereof |
-
2010
- 2010-12-01 CN CN2010105679519A patent/CN102485912A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1536088A (en) * | 2003-04-11 | 2004-10-13 | 徐定邦 | PCR method of multiple primer, its reaction liquor and application for preparing detection reagent |
CN1496413A (en) * | 2003-05-09 | 2004-05-12 | 清华大学 | Method for multiple PCR condition optimization and its component |
CN101851630A (en) * | 2009-03-30 | 2010-10-06 | 白向阳 | Human papillomavirus HPV DNA fragment, specific primer and application thereof |
Non-Patent Citations (1)
Title |
---|
MENG QIN,ET AL: "Detection of pandemic influenza A H1N1 virus by multiplex reverse transcription-PCR with a GeXP analyzer", 《JOURNAL OF VIROLOGICAL METHODS》, 7 May 2010 (2010-05-07), pages 255 - 258 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102994647A (en) * | 2012-06-21 | 2013-03-27 | 宁波海尔施基因科技有限公司 | Typing and quantitative detection method and kit for human papilloma virus (HPV) |
WO2013189306A1 (en) * | 2012-06-21 | 2013-12-27 | Ningbo Health Gene Technologies Co., Ltd. | Methods and compositions for assessing copy number of target polynecleotides |
CN102994647B (en) * | 2012-06-21 | 2014-11-19 | 宁波海尔施基因科技有限公司 | Typing and quantitative detection method and kit for human papilloma virus (HPV) |
CN113755641A (en) * | 2021-08-10 | 2021-12-07 | 中国疾病预防控制中心病毒病预防控制所 | Primer probe set and kit for isothermal nucleic acid amplification for detecting human papilloma virus types 16 and 18 |
CN113755641B (en) * | 2021-08-10 | 2024-01-26 | 中国疾病预防控制中心病毒病预防控制所 | Primer probe group and kit for detecting isothermal nucleic acid amplification of human papilloma virus type 16 and type 18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mirzamani et al. | Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization | |
CN107513584B (en) | A kind of five heavy fluorescence quantitative kits detecting enterovirus | |
CN103382507B (en) | 1 type and 3 type duck hepatitis A virus (HAV) single stage method dual RT-PCR detection kit, primer pair and method | |
CN101487063B (en) | Human papilloma virus infection gene amplification fluorescent detection kit | |
CN101435002B (en) | Method for detecting human papilloma virogene type | |
CN107177699A (en) | A kind of human papilloma virus(HPV)Parting quick determination method | |
CN105755169B (en) | Detection and typing kit for high-risk human papilloma virus and application thereof | |
Reich et al. | Possibly carcinogenic HPV subtypes are a cause of HSIL and negative clinical HPV tests–A European prospective single center study | |
CN104561372A (en) | Combined primer for amplification and typing of human papilloma virogenes and application of combined primer | |
CN101240351B (en) | Real time quantitative PCR determination method for lymphatic cyst virus | |
CN101613764B (en) | High-risk type HPV fluorescence PCR screening method and primer, probe and kit thereof | |
CN108330215A (en) | A kind of primer and probe compositions detecting high-risk 16 types of HPV using RPA technologies | |
CN103725793A (en) | Multiple fluorescent quantitative RT-PCR (reverse transcriptase-polymerase chain reaction) method for detecting PRRSV (porcine reproductive and respiratory syndrome virus) and application thereof | |
CN104560962B (en) | Fluorescent PCR kit and its primer special group for detecting HPV | |
CN104561384A (en) | HPV detection kit | |
CN105463132A (en) | Genetic marker of canine parvovirus and specific primers as well as probe thereof | |
CN106048081A (en) | HPV (human papilloma virus) typing detection primers as well as detection method and application thereof | |
CN102994647B (en) | Typing and quantitative detection method and kit for human papilloma virus (HPV) | |
CN101665834B (en) | Ki67mRNA real-time fluorescence quantitative RT-PCR detection reagent kit | |
CN101886137B (en) | Method for qualitatively detecting high-risk HPV by using fluorescence quantitative PCR and kit thereof | |
CN102485912A (en) | Research on GeXP multi-PCR technology for detecting and parting human papilloma virus (HPV) | |
CN105154584A (en) | HRM (high-resolution melting) label-free probe method, primer and probe for quickly differentiating PRRSV (porcine reproductive and respiratory syndrome virus) classical strains and mutant strains | |
CN101838709A (en) | Method for performing rapid gene typing on trace human papilloma virus (HPV) | |
KR101761701B1 (en) | HPV Specific Probe and DNA Chip for Detecting Genetic Type of HPV Containing Thereof | |
CN106048080A (en) | Primer and method for rapidly screening HPV (human papillomavirus) sub-types |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120606 |